樂
樂觀
樂觀 · 25%BDMD
$3.34
情境價格
$0.158
+0.070 (+44.36%)收盤時
Loading chart…
- 最高
- 0.195
- 開盤
- 0.102
- 成交量加權均價
- 0.15
- 成交量
- 380.62M
- 市值
- —
- 最低
- 0.100
- 成交金額
- 57.38M
- 企業價值/稅息折舊攤銷前利潤（TTM）
- 3.37
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
AI 分析 of Baird Medical Investment Holdings Ltd (BDMD)
賣出Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
估值指標
Baird Medical Investment Holdings Ltd（BDMD）目前預期本益比為 0.99，5 年平均預期本益比為 0.98。
Alphio AI 對 BDMD 的價格情境
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。
事件時間軸
資訊
8.511-05NewsfilterBaird Medical Partners with Alpmed to Advance IRE System
1.009-15Yahoo FinanceBaird Medical to Present at H.C. Wainwright Conference
- 8.508-20Newsfilter
Baird Medical Secures Product Registrations in Pakistan
7.508-11NASDAQ.COMBaird Medical and Alpmed Forge Strategic Partnership for IRE Technology
- 7.508-10Newsfilter
Baird Medical Partners with Alpmed for IRE Technology Development
BDMD 常見問題 —— 由 Alphio AI 解答
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market. It operates in the Healthcare sector.
Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
社群
更多 ↗
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。